Jim Wassil - 23 Dec 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Chief Operating Officer
Signature
Jim Wassil, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
23 Dec 2022
Net transactions value
+$254,998
Form type
4
Filing time
28 Dec 2022, 16:02:01 UTC
Previous filing
19 Oct 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $254,998 +105,371 +249% $2.42* 147,715 23 Dec 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -105,371 -47% $0.000000 116,555 23 Dec 2022 Common Stock 105,371 $2.42 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Common Stock received upon this option exercise remain subject to the restrictions on transfer set forth in a Lock-Up Agreement dated October 24, 2022.
F2 1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter.